Type 2 Diabetes and CKD

  • This topic has 12 replies, 11 voices, and was last updated 6 months ago by Stella.
Viewing 12 reply threads
  • Author
    Posts
    • #29444
      Faucy B
      Keymaster

      The Essentials Clinical Resource Tool (Annual)

      What are the barriers patients living with diabetes face most frequently when managing CKD?

    • #31193
      Annabelle Bittle
      Participant

      The Essentials Clinical Resource Tool (Annual)

      Lifestyle and motivation to improve health
      cost of medications

    • #31194
      RIAD MANSOUR
      Participant

      Diabetes Education

      patients do not realize importance of good bp and hba1c control.

    • #31195
      RIAD MANSOUR
      Participant

      Diabetes Education

      adding more medications.

    • #31196
      RIAD MANSOUR
      Participant

      Diabetes Education

      importance of good bs control.

    • #31226
      Veronica Tooley
      Participant

      Diabetes Education

      Patients can have long standing history of undiagnosed hyperteinsion and diabetes before they seek treatment. It can sometimes take a greater amount of time to get the patient to “buy in” on the importance of good control of blood pressure and glucose control in order to best manage the progression of their kidney disease.

    • #31240
      Kyla Aben
      Participant

      Diabetes Education

      The importance of regular follow up with health care team, BP monitoring/control, Glycemic monitoring(A1C)/control and making lifestyle modifications. Clients are often reluctant to add more medications to their regimen and changing focus from blood sugars control to possible kidney protection benefits, as adding more medications often causes clients to feel that they “failing” at controlling their blood glucose levels but there can be multiple benefits to making change. Clients have expressed that they feel that their HCP is constantly making medication changes and that they feel these changes are arbitrary, they often do not get the full information before a change is made for them, without their consult.

    • #31244
      Linda Kelland
      Participant

      Diabetes Education

      Patients unaware of the changes in the guidelines from Diabetes Canada and that there are newer classes of diabetic medications that not only decrease blood glucose, but have cardiorenal benefits. Convincing patients to change their existing therapy that may be controlling their blood glucose, but not providing cardiorenal benefits can be difficult at times. The costs of the GLP1 agonists and SGLT2 inhibitors can be a barrier for some patients.

    • #31257
      Lauren Xiaolin Deng
      Participant

      Diabetes Education

      Many of my patients resist to add additional medications due to a common health belief that drugs also cause kidney damage in the long run.

    • #31326
      Marlena Morrison
      Participant

      Diabetes Education

      Barriers to starting an SGLT2i include side effects associated with the medication. I find women in particular, who have a history of UTI or yeast infection, can be reluctant to start the medication or have sometimes had a poor experience with starting an SGLT2i in the past

    • #31384
      Ana Neves
      Participant

      Diabetes Education

      Lack of resources, health care support, accessibility, knowledge and ability to comprehend the importance of care

    • #31443
      Venugopal Namulla
      Participant

      Diabetes Education

      cost of meds, understanding the importance of any treatment changes

    • #31463
      Stella
      Participant

      The Essentials Clinical Resource Tool (Annual)

      For those who don’t have drug coverage. Cost of medication is a big factor.

Viewing 12 reply threads
  • You must be logged in to reply to this topic.
Scroll to Top

The
Essentials

Welcome,

Programs

Diabetes Canada

The Essentials